Pharmacology Flashcards
Isomerism
Structural - dynamic or static
Stereo - enantiomers or diastereoisomers
Chiral centre
Central atom bound to 4 dissimilar groups
Enantiomer
Stereoisomer with a single chiral centre, producing non-superimposable isomers
Tautomerism
Dynamic change between 2 different forms depending on environmental conditions, often pH
Optical isomerism
Ability to rotate polarised light in different directs
What is the time constant?
Time taken for plasma conc to fall to 0 if initial rate of elimination continued
Reciprocal of the rate constant 1/e
Always longer than half life (half life is shorter by a factor of 0.693)
Clearance
Volume of plasma cleared per unit time
Cl = Input/plasma conc
Cl = Ke x Vd (where Ke is elimination rate constant)
Loading dose - equation
Vd * desired concentration
Maintenance dose - equation
Steady state con x clearance
Zero Order Kinetics
Independent of the conc of reactants
Constant amount
Fixed amount cleared; half life decrease
No steady state reached - accumulation will occur e.g. ethanol
(may be due to maximal enzyme activity - some reactions will initially be first order then at saturation point become zero order e.g thiopentone)
Horizontal line on graph
First Order Kinetics
Dependent on conc of reactants.
Constant proportion
Half life and clearance are constant
Reaches steady state - doesn’t accumulate - propofol
Michaelis-Menten Equation
Predicts rate according to substrate concentration and specific enzyme characteristics
V= Vmax[substrate]/Km + [substrate]
Where Km = substrate conc at which velocity is half of max (equivalent to ED50)
Agonists
Demonstrate affinity and intrinsic activity;
full agonists = 1
partial agonists < 1
Antagonists
Demonstrate affinity but no intrinsic activity
Competitive antagonists:
-same site binding
-shift the dose response to the right, but can achieve the same Emax with increased dose
Non-competitive antagonists
-allosteric binding
-reduce the Emax, effect not overcome by ^^ dose
Mixed agonist/antagonists
Opioids - pentazocine, buprenorphine
Mirtazepine
Pindolol, xameterol
Volume of Distribution
Theoretical volume a drug would have to occupy to produce plasma conc.
Vd= dose/conc
Small non polar molecules distribute freely = large Vd 40L
Small polar molecules exit circulation to ECF = Vd ~ 14L
Large polar molecules trapped in circulation = small Vd 5l
When can Vd be larger than total body water?
This effect can be due to protein binding, plasma degradation, sequestration into other tissues e.g. propofol into adipose
Extraction ratio
The efficiency of an organ in eliminating a drug
If ER is high, then clearance depends only on blood flow.
Phase 1 Elimination Reactions
Makes a substance water soluble, unmasks function group
CYP450 reactions;
oxidation - barbs, benzos, paracetamol, omeprazole
reduction - prednisone to prednisolone
hydrolysis - mao > adrenaline, esterases > remifentanil, atracurium, alcohol dehydrogenase > ethanol to acetic acid
Phase 2 Elimination Reactions
Conjugation with a functional group
Glucuronidation - morphine activation, propofol inactiv
Acetylation - isoniazid, hydralazine
Sulphation - paracetamol
Methylation - catecholamines
Glutathione conjug - paracetamol
TCI Models
Marsh
Developed for plasma effect site
Requires lean body weight
TCI Models
Schnider
Requires ABW, age, height, gender
Smaller initial bolus so safer for old/frail/high ASA
Efficacy
Magnitude of receptor response
Affinity
Ability to bind to receptor
Reciprocal of the equilibrium dissociation constant